1,055 filings
Page 33 of 53
8-K/A
ORKA
Oruka Therapeutics Inc.
27 Dec 11
Entry into a Material Definitive Agreement
12:00am
8-K
ORKA
Oruka Therapeutics Inc.
22 Dec 11
Arca Biopharma Announces Private Placement of $1.75 Million
12:00am
8-K
ORKA
Oruka Therapeutics Inc.
17 Nov 11
Gencarotm Demonstrated 74% Risk Reduction for New Onset
12:00am
10-Q
2011 Q3
ORKA
Oruka Therapeutics Inc.
Quarterly report
14 Nov 11
12:00am
8-K
ORKA
Oruka Therapeutics Inc.
14 Nov 11
Other Events
12:00am
10-Q
2011 Q2
ORKA
Oruka Therapeutics Inc.
Quarterly report
15 Aug 11
12:00am
8-K
ORKA
Oruka Therapeutics Inc.
24 Jun 11
Other Events
12:00am
8-K
ORKA
Oruka Therapeutics Inc.
20 Jun 11
Entry into a Material Definitive Agreement
12:00am
CT ORDER
ORKA
Oruka Therapeutics Inc.
15 Jun 11
Confidential treatment order
12:00am
8-K
ORKA
Oruka Therapeutics Inc.
26 May 11
Arca Biopharma Announces Planned Expansion of Gencaro
12:00am
8-K
ORKA
Oruka Therapeutics Inc.
24 May 11
Termination of a Material Definitive Agreement
12:00am
8-K
ORKA
Oruka Therapeutics Inc.
23 May 11
Submission of Matters to a Vote of Security Holders
12:00am
10-Q
2011 Q1
ORKA
Oruka Therapeutics Inc.
Quarterly report
16 May 11
12:00am
8-K
ORKA
Oruka Therapeutics Inc.
3 May 11
Arca Biopharma Signs Global Rights Agreement with Large
12:00am
424B5
ORKA
Oruka Therapeutics Inc.
18 Apr 11
Prospectus supplement for primary offering
12:00am
8-K
ORKA
Oruka Therapeutics Inc.
18 Apr 11
Entry into a Material Definitive Agreement
12:00am
8-K
ORKA
Oruka Therapeutics Inc.
18 Apr 11
Arca Biopharma Announces $3 Million Equity Offering
12:00am
8-K
ORKA
Oruka Therapeutics Inc.
5 Apr 11
Entry into a Material Definitive Agreement
12:00am
EFFECT
ORKA
Oruka Therapeutics Inc.
4 Apr 11
Notice of effectiveness
12:00am
CORRESP
ORKA
Oruka Therapeutics Inc.
31 Mar 11
Correspondence with SEC
12:00am